“◐저질러봐◑여탑 WWW˛ yeotop5 .Com 백운동오피Ⅴ백운동휴게텔✵백운동오피ぅ백운동출장❐백운동마사지✆백운동안마❞백운동OP”的搜索结果，显示 101-110 项，共有 15005 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute ...

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... (5) advanced, unresectable colorectal cancer, (6) advanced, unresectable ovarian cancer, (7) advanced, unresectable clear cell kidney cancer, (8) advanced ...

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... (5) advanced, unresectable colorectal cancer, (6) advanced, unresectable ovarian cancer, (7) advanced, unresectable clear cell kidney cancer, (8) advanced ...

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   （仅限开放性研究）. 按位置、状态和其他条件筛选该研究列表。 Effects of Cognitive Function, Post-op Fatigue and Quality of Life ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. This phase II trial studies how well inotuzumab ozogamicin works in treating younger patients with CD22 positive B acute lymphoblastic leukemia ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... (5) advanced, unresectable colorectal cancer, (6) advanced, unresectable ... The primary endpoint is EFS and 774 eligible and evaluable patients are anticipated to ...

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... (5) advanced, unresectable colorectal cancer, (6) advanced, unresectable ... The primary endpoint is EFS and 774 eligible and evaluable patients are anticipated to ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   以下为当前的临床试验。 ... （仅限开放性研究）. 按位置、状态和其他条件筛选该研究列表。 Effects of Cognitive Function, Post-op ...

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    Effects of Cognitive Function, Post-op Fatigue and Quality of Life Comparing General vs Regional Anesthesia for Non-eloquent Brain Tumors Resection.